Literature DB >> 8698391

Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine.

R A Wilson1, P S Coulson, C Betts, M A Dowling, L E Smythies.   

Abstract

A high level of protection against Schistosoma mansoni is elicited in mice by the irradiated cercaria vaccine and interferon-gamma (IFN-gamma) is a key cytokine in the pulmonary effector response. The role of this cytokine has been investigated in mice with a targeted disruption of the IFN-gamma receptor gene (IFN-gamma R-/- mice). The level of protection was impaired relative to that elicited in C57BL/6 and 129 wild-type (WT) animals. These two groups developed compact effector foci, of largely mononuclear cell composition, around individual challenge parasites migrating through the lungs. In contrast the IFN-gamma R-/- mice showed a massive and generalized leucocytic infiltration of the airways and interstitium in which eosinophils were a prominent feature. Cultures of airway leucocytes from C57BL/6 mice produced abundant IFN-gamma whilst those from IFN-gamma R-/- mice produced interleukin-4 (IL-4), IL-5 and IL-10, indicating default to the Th2 pathway; the WT animals showed an intermediate response. The pattern of cytokine gene transcripts in whole lung tissue agreed remarkably well with the level of cytokine protein detected in leucocyte cultures, with the exception of substantial IL-4 mRNA but negligible protein in C57BL/6 mice. The loose but intense infiltrate of leucocytes in the lungs of IFN-gamma R-/- mice was clearly ineffective in eliminating challenge parasites, whereas the level of IFN-gamma protein and mRNA in the lungs of C57BL/6 and WT mice correlated with the size and compactness of effector foci. On the basis of these and earlier observations, we suggest that a primary role for IFN-gamma is to promote intercellular adhesion between the leucocytes in an effector focus, promoting its ability to block parasite migration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698391      PMCID: PMC1384285          DOI: 10.1046/j.1365-2567.1996.465550.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

1.  Vaccines against schistosomiasis: where do we stand?

Authors:  A E Butterworth
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Jan-Feb       Impact factor: 2.184

2.  Migration of the schistosomula of Schistosoma mansoni in mice vaccinated with radiation-attenuated cercariae, and normal mice: an attempt to identify the timing and site of parasite death.

Authors:  R A Wilson; P S Coulson; B Dixon
Journal:  Parasitology       Date:  1986-02       Impact factor: 3.234

3.  Vaccines against schistosomes: an alternative view.

Authors:  R A Wilson; A Sher
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Mar-Apr       Impact factor: 2.184

4.  Lung-phase immunity to Schistosoma mansoni. Flow cytometric analysis of macrophage activation states in vaccinated mice.

Authors:  E N Menson; R A Wilson
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

5.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

Authors:  K W Moore; P Vieira; D F Fiorentino; M L Trounstine; T A Khan; T R Mosmann
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

6.  Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo.

Authors:  E J Pearce; S L James
Journal:  Parasite Immunol       Date:  1986-09       Impact factor: 2.280

7.  Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. I. Analysis of antibody and T-lymphocyte responses in mouse strains developing differing levels of immunity.

Authors:  S L James; M Labine; A Sher
Journal:  Cell Immunol       Date:  1981-11-15       Impact factor: 4.868

8.  Antigen localization and the induction of resistance in mice vaccinated with irradiated cercariae of Schistosoma mansoni.

Authors:  A P Mountford; P S Coulson; R A Wilson
Journal:  Parasitology       Date:  1988-08       Impact factor: 3.234

9.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  26 in total

1.  The radiation-attenuated schistosome vaccine induces high levels of protective immunity in the absence of B cells.

Authors:  S Anderson; P S Coulson; S Ljubojevic; A P Mountford; R A Wilson
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

2.  Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses.

Authors:  A P Mountford; P S Coulson; A W Cheever; A Sher; R A Wilson; T A Wynn
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

3.  Immunization with recombinant schistosome adenylate kinase 1 partially protects mice against Schistosoma japonicum infection.

Authors:  Yanru Gao; Xiaoshan Zhou; Huan Wang; Rong Liu; Qing Ye; Qinping Zhao; Zhenping Ming; Huifen Dong
Journal:  Parasitol Res       Date:  2017-04-28       Impact factor: 2.289

4.  Interleukin-12 modulates T-cell responses to microfilariae but fails to abrogate interleukin-5-dependent immunity in a mouse model of onchocerciasis.

Authors:  P J Hogarth; A E Bianco
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

5.  Mice lacking the gamma interferon receptor have an impaired granulomatous reaction to Schistosoma mansoni infection.

Authors:  S A Rezende; V R Oliveira; A M Silva; J B Alves; A M Goes; L F Reis
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Signaling via interleukin-4 receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice.

Authors:  A P Mountford; K G Hogg; P S Coulson; F Brombacher
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection.

Authors:  B A Garvy; R A Ezekowitz; A G Harmsen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

8.  Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination.

Authors:  P S Coulson; L E Smythies; C Betts; N A Mabbott; J M Sternberg; X G Wei; F Y Liew; R A Wilson
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

9.  Th1 cytokine mRNA expression dominates in the skin-draining lymph nodes of C57BL/6 mice following vaccination with irradiated Schistosoma mansoni cercariae, but is down-regulated upon challenge infection.

Authors:  C J Betts; R A Wilson
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

10.  In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni.

Authors:  James P Hewitson; Paul A Hamblin; Adrian P Mountford
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.